Chemical Compound
ABT-494; rel-(-)-(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide
CAS Registry Number
1310726-60-3
Primary record
ABT-494; rel-(-)-(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide
- 库存
- 3,058 克
- 纯度
- 99.6 %
- CAS
- 1310726-60-3
化合物标识与属性
- CAS
- 1310726-60-3
- PubChem CID
- 58557659
- SMILES
- CC[C@@H]1CN(C[C@@H]1C2=CN=C3N2C4=C(NC=C4)N=C3)C(=O)NCC(F)(F)F
- Canonical SMILES
- CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12
名称与同义词
- Upadacitinib
- Rinvoq
- ABT-494
- 1310726-60-3
- upadacitinibum
- Upadicitinib
- Upadacitinib anhydrous
- upadacitinib hydrate
- Upadacitinib [USAN]
- ABT-494 enantiomer
- Upadacitinib (Standard)
- RefChem:57163
- 4RA0KN46E0
- UNII-4RA0KN46E0
- UPADACITINIB [MI]
- Upadacitinib, ABT-494
- Upadacitinib (USAN/INN)
- UPADACITINIB [INN]
- Upadacitinib [USAN:INN]
- Upadacitinib (ABT-494)
- C17H19F3N6O
- UPADACITINIB [WHO-DD]
- ABT 494
- DTXSID901027919
- GTPL9246
- orb1299762
- SCHEMBL9991056
- CHEMBL3622821
- L04AA44
- MFCD30502663
- WYQFJHHDOKWSHR-MNOVXSKESA-N
- DTXCID401513480
- GLXC-10425
- UPADACITINIB [ORANGE BOOK]
- AMY16528
- BCP19011
- EX-A1628
- BDBM50503287
- EBC-26865
- HY-19569R
- MFCD30738063
- s8162
- AKOS030567686
- ACN-052823
- CS-6150
- DB15091
- ABBV-599 COMPONENT UPADACITINIB
- ABT494;ABT-494;ABT 494
- NCGC00588874-01
- AC-30326
- AS-56379
- DA-78788
- FA166721
- HY-19569
- NS00133778
- J3.590.729G
- C72237
- D10994
- A857968
- (3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
- Q27074125
- (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
- Z2831495606
- B0084-475295
- (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide
- (3S,4R)-3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide
- (3R)-N-(2,2,2-Trifluoroethyl)-3alpha-(3H-3,4,6,8a-tetraaza-as-indacene-8-yl)-4alpha-ethylpyrrolidine-1-carboxamide
- (3S,4R)-3- Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide
- (3S,4R)-3-ethyl-4-(1,5,7,10-tetraazatricyclo(7.3.0.0^(2,6))dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
- (3S,4R)-3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2- trifluoroethyl)pyrrolidine-1-carboxamide
- (3S,4R)-3-ethyl-4-{1,5,7,10-tetraazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl}-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
- 1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, (3S,4R)-
- 1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, (3S,4R)-
- 1310726-59-0
- 1831899-72-9
- ABT-494; rel-(-)-(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide
- N-(2,2,2-Trifluoroethyl)-3beta-ethyl-4beta-(3H-4,6,8a-triazacyclopenta[e]indole-8-yl)pyrrolidine-1-carboxamide
- rel-(-)-(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
- rel-(3R,4S)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide